RCS - Worldwide Healthcare - Edison issues review on Worldwide Healthcare Trust

Worldwide Healthcare TrustAnnouncement

26/07/2022 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220726:nRSZ7475Ta&default-theme=true

RNS Number : 7475T  Worldwide Healthcare Trust PLC  26 July 2022

London, UK, 26 July 2022

 

Edison issues review on Worldwide Healthcare Trust (WWH)

Worldwide Healthcare Trust (WWH) has two co-managers, Sven Borho and Trevor
Polischuk at global healthcare specialist OrbiMed. Borho recently presented at
the WWH AGM and despite disappointing performance in FY22 (March year-end),
which he notes was a 'mirror image' of FY21, the manager remains optimistic
about the trust's prospects. He is hopeful that May/June 2022 marked the low
point in the absolute and relative performance of biotech stocks and is
confident that the focus on favouring emerging biotech and emerging market
stocks over large-cap pharma companies will once again be the correct strategy
for WWH's shareholders. Borho considers that the trust's portfolio offers
investors a 'mix of the big guys', which gives some stability, along with
'explosive growth' companies, and this approach has delivered significant
outperformance versus WWH's benchmark over the long term.

 

WWH's shares are trading at a 6.9% discount to its cum-income NAV, which is
wider than the 0.3% to 3.3% range of average discounts over the last one,
three, five and 10 years. This may be due to a period of meaningful
underperformance versus the trust's benchmark in FY22. WWH's board employs a
discount-control mechanism, aiming to ensure a maximum 6% share price discount
to ex-income NAV in normal market conditions.

Click here
(https://www.edisongroup.com/publication/manager-suggests-may-2022-was-inflexion-point/31133/?utm_campaign=RNSreach%20Press%20Releases&utm_source=RNSreach&utm_medium=Press%20Release)
to view the full report or here
(https://share.hsforms.com/1uMgrR7_WSJuk9T81eYT_Gg3k1vq) to sign up to receive
research as it is published.

 

All reports published by Edison are available to download free of charge from
its website

www.edisongroup.com (http://www.edisongroup.com)

About Edison: Edison is a leading research and investor relations consultancy,
connecting listed companies to the widest pool of global investors. By
focusing on the volume and quality of investors reached - across institutions,
family offices, wealth managers and retail investors - Edison can create and
gauge intent to purchase, even in the darkest pools of capital, and then make
introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100
analysts covering every economic sector. Headquartered in London, Edison also
has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in
Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority
(https://register.fca.org.uk/ShPo_FirmDetailsPage?id=001b000000MfYL6AAN) .

Edison is not an adviser or broker-dealer and does not provide investment
advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com (http://www.edisongroup.com) and connect
with Edison on:

LinkedIn        www.linkedin.com/company/edison-group-/
(http://www.linkedin.com/company/edison-group-/)

Twitter             www.twitter.com/Edison_Inv_Res
(http://www.twitter.com/Edison_Inv_Res)

YouTube       www.youtube.com/edisonitv
(http://www.youtube.com/edisonitv)

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRARFMRTMTITMPT